About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Houston | 515 Studies

Clinical Trials Prostate CancerHouston

Prostate Cancer Clinical Trials in Houston

Find 515 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 515 trials

CompletedA Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThe primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide…NCT02799745·Birmingham, Alabama and 53 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingTrial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate CancerThe primary objective of this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate…NCT07493512·Denver, Colorado and 13 others

TerminatedA Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor CancerThe purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.NCT04586270·Nashville, Tennessee and 3 others

RecruitingSacral Neuromodulation for Male Overactive Bladder (MOAB)To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.NCT06511141·Birmingham, Alabama and 22 others

RecruitingA Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerMedicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer.NCT04729114·Tucson, Arizona and 24 others

TerminatedA Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid TumorsThis is an open-label, dose escalation and dose expansion study of MDK-703 as a monotherapy and in combination with other cancer therapies in adult study participants with…NCT05716295·Sarasota, Florida and 5 others

WithdrawnAntineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate CancerCurrent therapies for Refractory Stage IV Prostate Cancer provide very limited benefit to the patient.NCT00003534·Houston, Texas

SuspendedA Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NPX267 is an antibody drug targeting the inhibitory receptor for B7-H7 (HHLA2) which may control evasion of the immune response in tumors.NCT05958199·Baltimore, Maryland and 6 others

UnknownEnd of Life Treatment Preferences of Latino Medicare Beneficiaries With CancerObjectives: The primary objective of the research project is to investigate how declining health status influences the end-of-life (EOL) treatment preferences in Latino Medicare…NCT01389830·Houston, Texas

Active not recruitingTalazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCThis study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with…NCT03395197·Anchorage, Alaska and 369 others

CompletedRidaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)The purpose of this study is to assess the antitumor activity of weekly ridaforolimus study treatment in participants with taxane-resistant AIPC.NCT00110188·Los Angeles, California and 3 others

RecruitingPRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.To look at the safety and effectiveness of stereotactic body radiation therapy (SBRT) in treating advanced or high-risk prostate cancer.NCT06369246·Houston, Texas

Not yet recruitingiCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate CancerThis trial is aimed to better understand the impact of migration history on the quality of life of Black immigrant CaP survivors (both SSAI and CI).NCT07105020·Houston, Texas

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

CompletedStudy of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100This study will evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with…NCT01605227·Birmingham, Alabama and 263 others

Active not recruitingAbiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerThis randomized phase II trial studies the side effects and how well abiraterone acetate, prednisone, and apalutamide work with or without ipilimumab or cabazitaxel and…NCT02703623·Houston, Texas and 2 others

CompletedStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.The main purpose of this first human study with CC-115 is to assess the safety and action of a new class of experimental drug (dual DNA-PK and TOR kinase inhibitors) in patients…NCT01353625·Los Angeles, California and 16 others

CompletedHormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerPrimary Objective: 1\. To evaluate the pathological complete response rate to neoadjuvant hormonal ablation, Imatinib and Docetaxel (HID) in high-risk localized prostate cancer.NCT00500110·Houston, Texas

UnknownStudy of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsStudy of NGM438 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid TumorsNCT05311618·Denver, Colorado and 5 others

CompletedNerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerRATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate…NCT00080808·Houston, Texas

PreviousPage 9 of 26Next

Other Conditions in Houston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma